John Bridgewater

机构：University College Hospital, Centre National de la Recherche Scientifique, University College London Hospitals NHS Foundation Trust, Inserm, Cancer Research UK, Sorbonne Université, London Cancer, CRUK Lung Cancer Centre of Excellence, Institut du Cerveau, University College London · ORCID：0000-0001-9186-1604

发表论文 451 篇 · 总被引 36996 次 · h-index 67

代表论文

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 53)
• New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe (2025 · The Lancet Regional Health - Europe · 被引 24)
• Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10—Precision Medicine) (2025 · ESMO Open · 被引 14)
• Epigenetically driven and early immune evasion in colorectal cancer evolution (2025 · Nature Genetics · 被引 11)
• Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer (2025 · JAMA Oncology · 被引 7)
• Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative Review (2025 · Oncology and Therapy · 被引 4)